Chiara Biagioni

1.5k total citations
45 papers, 960 citations indexed

About

Chiara Biagioni is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Chiara Biagioni has authored 45 papers receiving a total of 960 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Oncology, 20 papers in Molecular Biology and 20 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Chiara Biagioni's work include Advanced Breast Cancer Therapies (17 papers), HER2/EGFR in Cancer Research (10 papers) and Cancer Genomics and Diagnostics (9 papers). Chiara Biagioni is often cited by papers focused on Advanced Breast Cancer Therapies (17 papers), HER2/EGFR in Cancer Research (10 papers) and Cancer Genomics and Diagnostics (9 papers). Chiara Biagioni collaborates with scholars based in Italy, United States and Belgium. Chiara Biagioni's co-authors include Angelo Di Leo, Luca Malorni, Ilenia Migliaccio, Francesca Galardi, Laura Biganzoli, Martina Bonechi, Matteo Benelli, Dario Romagnoli, Cristina Guarducci and Marta Pestrin and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Clinical Cancer Research.

In The Last Decade

Chiara Biagioni

44 papers receiving 946 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Chiara Biagioni Italy	17	614	509	363	262	155	45	960
Pietro De Placido Italy	13	488 0.8×	396 0.8×	225 0.6×	245 0.9×	77 0.5×	53	816
Marta Palafox Spain	9	604 1.0×	482 0.9×	245 0.7×	393 1.5×	153 1.0×	12	914
Valerie M. Jansen United States	14	583 0.9×	479 0.9×	273 0.8×	304 1.2×	124 0.8×	38	896
Emanuela Risi Italy	15	411 0.7×	378 0.7×	178 0.5×	238 0.9×	86 0.6×	39	673
Thehang Luu United States	18	651 1.1×	193 0.4×	295 0.8×	639 2.4×	49 0.3×	43	1.2k
Alexandr Poprach Czechia	21	433 0.7×	632 1.2×	848 2.3×	981 3.7×	75 0.5×	107	1.6k
Cataldo Bianco Italy	24	765 1.2×	427 0.8×	252 0.7×	757 2.9×	128 0.8×	37	1.5k
Jianbo He United States	17	301 0.5×	102 0.2×	224 0.6×	487 1.9×	125 0.8×	49	1.1k
Carmen Dekmezian United States	6	491 0.8×	85 0.2×	425 1.2×	560 2.1×	142 0.9×	8	974
Eriko Katsuta United States	24	695 1.1×	403 0.8×	501 1.4×	773 3.0×	30 0.2×	82	1.6k

Countries citing papers authored by Chiara Biagioni

Since Specialization

Citations

This map shows the geographic impact of Chiara Biagioni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chiara Biagioni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chiara Biagioni more than expected).

Fields of papers citing papers by Chiara Biagioni

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chiara Biagioni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chiara Biagioni. The network helps show where Chiara Biagioni may publish in the future.

Co-authorship network of co-authors of Chiara Biagioni

This figure shows the co-authorship network connecting the top 25 collaborators of Chiara Biagioni. A scholar is included among the top collaborators of Chiara Biagioni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chiara Biagioni. Chiara Biagioni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Migliaccio, Ilenia, Dario Romagnoli, Francesca Galardi, et al.. (2024). Mutational Analysis of Circulating Tumor DNA in Patients With Estrogen Receptor–Positive/Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer Receiving Palbociclib: Results From the TREnd Trial. JCO Precision Oncology. 8(8). e2300285–e2300285. 4 indexed citations

Romagnoli, Dario, Agostina Nardone, Francesca Galardi, et al.. (2023). MIMESIS: minimal DNA-methylation signatures to quantify and classify tumor signals in tissue and cell-free DNA samples. Briefings in Bioinformatics. 24(2). 1 indexed citations

Benelli, Matteo, Antonio Nardone, Francesca Galardi, et al.. (2023). 2272P Minimal DNA-methylation (DNAm) signatures for non-invasive tumor-agnostic estimation of tumor content (TC) and molecular subtype in patients (pts) with metastatic breast cancer (mBC). Annals of Oncology. 34. S1166–S1166. 1 indexed citations

Risi, Emanuela, C. Lisanti, Alessia Vignoli, et al.. (2022). Risk assessment of disease recurrence in early breast cancer: A serum metabolomic study focused on elderly patients. Translational Oncology. 27. 101585–101585. 2 indexed citations

Migliaccio, Ilenia, Emanuela Risi, Chiara Biagioni, et al.. (2022). PIK3CA co-occurring mutations and copy-number gain in hormone receptor positive and HER2 negative breast cancer. npj Breast Cancer. 8(1). 24–24. 10 indexed citations

Donato, Samantha Di, Alessia Vignoli, Chiara Biagioni, et al.. (2021). A Serum Metabolomics Classifier Derived from Elderly Patients with Metastatic Colorectal Cancer Predicts Relapse in the Adjuvant Setting. Cancers. 13(11). 2762–2762. 17 indexed citations

Vignoli, Alessia, Elena Mori, Samantha Di Donato, et al.. (2021). Exploring Serum NMR-Based Metabolomic Fingerprint of Colorectal Cancer Patients: Effects of Surgery and Possible Associations with Cancer Relapse. Applied Sciences. 11(23). 11120–11120. 3 indexed citations

Benelli, Matteo, Gian Marco Franceschini, Alberto Magi, et al.. (2021). Charting differentially methylated regions in cancer with Rocker-meth. Communications Biology. 4(1). 1249–1249. 8 indexed citations

Galardi, Francesca, Francesca De Luca, Chiara Biagioni, et al.. (2021). Circulating tumor cells and palbociclib treatment in patients with ER-positive, HER2-negative advanced breast cancer: results from a translational sub-study of the TREnd trial. Breast Cancer Research. 23(1). 38–38. 25 indexed citations

10.

McCartney, Amelia, Martina Bonechi, Francesca De Luca, et al.. (2020). Plasma Thymidine Kinase Activity as a Biomarker in Patients with Luminal Metastatic Breast Cancer Treated with Palbociclib within the TREnd Trial. Clinical Cancer Research. 26(9). 2131–2139. 37 indexed citations

11.

Rossi, Lorenzo, Chiara Biagioni, Amelia McCartney, et al.. (2019). Clinical outcomes after palbociclib with or without endocrine therapy in postmenopausal women with hormone receptor positive and HER2-negative metastatic breast cancer enrolled in the TREnd trial. Breast Cancer Research. 21(1). 71–71. 20 indexed citations

12.

Guarducci, Cristina, Martina Bonechi, Matteo Benelli, et al.. (2018). Cyclin E1 and Rb modulation as common events at time of resistance to palbociclib in hormone receptor-positive breast cancer. npj Breast Cancer. 4(1). 38–38. 86 indexed citations

13.

Romagnoli, Dario, Giulia Boccalini, Martina Bonechi, et al.. (2018). ddSeeker: a tool for processing Bio-Rad ddSEQ single cell RNA-seq data. BMC Genomics. 19(1). 960–960. 16 indexed citations

14.

Risi, Emanuela, Andrea Grilli, Ilenia Migliaccio, et al.. (2018). A gene expression signature of Retinoblastoma loss-of-function predicts resistance to neoadjuvant chemotherapy in ER-positive/HER2-positive breast cancer patients. Breast Cancer Research and Treatment. 170(2). 329–341. 18 indexed citations

15.

Malorni, Luca, Silvano Piazza, Yari Ciani, et al.. (2016). A gene expression signature of retinoblastoma loss-of-function is a predictive biomarker of resistance to palbociclib in breast cancer cell lines and is prognostic in patients with ER positive early breast cancer. Oncotarget. 7(42). 68012–68022. 104 indexed citations

16.

Jeselsohn, Rinath, William T. Barry, Ilenia Migliaccio, et al.. (2016). TransCONFIRM: Identification of a Genetic Signature of Response to Fulvestrant in Advanced Hormone Receptor–Positive Breast Cancer. Clinical Cancer Research. 22(23). 5755–5764. 20 indexed citations

17.

Donato, Samantha Di, Anna Rachelle Mislang, Alessia Vignoli, et al.. (2016). Serum metabolomic as biomarkers to differentiate early from metastatic disease in elderly colorectal cancer (crc) patients. Annals of Oncology. 27. iv45–iv45. 1 indexed citations

18.

Malorni, Luca, Chiara Biagioni, J. Thirlwell, et al.. (2014). Efficacy of Fulvestrant According to Duration and Type of Adjuvant Endocrine Treatment, in Metastatic Breast Cancer Patients Enrolled in the Confirm Trial. Annals of Oncology. 25. i8–i8. 1 indexed citations

19.

Pestrin, Marta, Silvia Bessi, Francesca Galardi, et al.. (2009). Correlation of HER2 status between primary tumors and corresponding circulating tumor cells in advanced breast cancer patients. Breast Cancer Research and Treatment. 118(3). 523–530. 169 indexed citations

20.

Catarzi, Serena, Chiara Biagioni, Elisa Giannoni, et al.. (2005). Redox regulation of platelet-derived-growth-factor-receptor: Role of NADPH-oxidase and c-Src tyrosine kinase. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1745(2). 166–175. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact